---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-389264"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2026-09-11T20:05:52+00:00"
generated_at: "2026-09-11T20:07:13.113396+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teva prices $4.9B senior notes to refinance higher-coupon debt

## Summary
- EUR tranches: €1.0B 4.250% due 2033, €500M 4.625% due 2036.
- USD tranches: $1.0B 5.500% due 2034, $1.0B 5.750% due 2037, $1.2B 5.250% due 2032.
- Closing expected Sept 16, 2026; senior unsecured, guaranteed by Teva.
- Proceeds fund redemptions: all 6.750% 2028, 7.875% 2029, 7.375% 2029, up to $450M 4.750% 2027, €1.25B 4.375% 2030 (reduced to €1.15B).
- Also plans to redeem all 8.125% 2031 notes; remainder for general corporate purposes.

## SEC filing metadata
- accession: 0001193125-26-389264
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2026-09-11T20:05:52+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312526389264/0001193125-26-389264-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312526389264/d81245d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-389264
- JSON: https://secwatch.observer/filing/0001193125-26-389264.json
- Plain text: https://secwatch.observer/filing/0001193125-26-389264.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.